International Biotechnology Trust (IBT)

Category Sector Equity Biotechnology
star-filledstar-filledstar-filledstar-filled
This investment trust can be held in an Investment ISA, SIPP and Investment Account
Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show ongoing charges as 0% or a dash please review the investment literature for details on the charges that will apply.

If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
Sell

934.00p

Buy

942.00p

arrow-down-2.00p (-0.21%)

Discount/Premium

-10.24%

Estimated NAV

1,040.595p

Prices updated at 02 Apr 2026, 16:35 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Investment objective
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with suitably experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
FTSE All-Share
arrow-up0.59%
LSE
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Portfolio as of 28/02/2026

Asset allocation

Show long & short position

Geographical breakdown

Continent or country allocation (%)

Market classification (%)

Top 10 holdings

1
Alnylam Pharmaceuticals Inc
Sector
-
Country
United States
% of assets
5.07387
2
Soleno Therapeutics Inc
Sector
-
Country
United States
% of assets
4.57492
3
KalVista Pharmaceuticals Inc
Sector
-
Country
United States
% of assets
4.16728
4
Ascendis Pharma AS ADR
Sector
-
Country
Denmark
% of assets
3.43551
5
Autolus Therapeutics PLC ADR
Sector
-
Country
United States
% of assets
3.404
6
Sv Bcof
Sector
-
Country
-
% of assets
3.36919
7
NovoCure Ltd
Sector
-
Country
United States
% of assets
2.89595
8
Madrigal Pharmaceuticals Inc
Sector
-
Country
United States
% of assets
2.85179
9
Neurocrine Biosciences Inc
Sector
-
Country
United States
% of assets
2.65076
10
CG Oncology Inc
Sector
-
Country
United States
% of assets
2.56472
Assets in top 10 holdings %

34.99%

Total no. of equity holdings

83.00

Total no. of bond holdings

1.00

Stock sectors

International Biotechnology Trust
Sector Equity Biotechnology

0.00%

Basic materials

-
-

Con cyclical

-
-

Financial svs

-
-

Real estate

-
-

0.00%

Comm services

-
-

Energy

-
-

Industrials

-
-

Technology

-
-

100.00%

Con defensive

-
-

Healthcare

100.00%
-

Utilities

-
-


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2026 Morningstar. All rights reserved.